Cargando…

Lipidome in colorectal cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths. Understanding its pathophysiology is essential for developing efficient strategies to treat this disease. Lipidome, the sum of total lipids, related enzymes, receptors and signaling pathways, plays crucial roles in multipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Guifang, Li, Liqi, Zhu, Bo, Li, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078107/
https://www.ncbi.nlm.nih.gov/pubmed/26967051
http://dx.doi.org/10.18632/oncotarget.7960
_version_ 1782462314417487872
author Yan, Guifang
Li, Liqi
Zhu, Bo
Li, Yongsheng
author_facet Yan, Guifang
Li, Liqi
Zhu, Bo
Li, Yongsheng
author_sort Yan, Guifang
collection PubMed
description Colorectal cancer (CRC) is the second leading cause of cancer-related deaths. Understanding its pathophysiology is essential for developing efficient strategies to treat this disease. Lipidome, the sum of total lipids, related enzymes, receptors and signaling pathways, plays crucial roles in multiple cellular processes, such as metabolism, energy storage, proliferation and apoptosis. Dysregulation of lipid metabolism and function contributes to the development of CRC, and can be used towards the evaluation of prognosis. The strategies targeting lipidome have been applied in clinical trails and showed promising results. Here we discuss recent advances in abnormal lipid metabolism in CRC, the mechanisms by which the lipidome regulates tumorigenesis and tumor progression, and suggest potential therapeutic targets for clinical trials.
format Online
Article
Text
id pubmed-5078107
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-50781072016-10-28 Lipidome in colorectal cancer Yan, Guifang Li, Liqi Zhu, Bo Li, Yongsheng Oncotarget Review Colorectal cancer (CRC) is the second leading cause of cancer-related deaths. Understanding its pathophysiology is essential for developing efficient strategies to treat this disease. Lipidome, the sum of total lipids, related enzymes, receptors and signaling pathways, plays crucial roles in multiple cellular processes, such as metabolism, energy storage, proliferation and apoptosis. Dysregulation of lipid metabolism and function contributes to the development of CRC, and can be used towards the evaluation of prognosis. The strategies targeting lipidome have been applied in clinical trails and showed promising results. Here we discuss recent advances in abnormal lipid metabolism in CRC, the mechanisms by which the lipidome regulates tumorigenesis and tumor progression, and suggest potential therapeutic targets for clinical trials. Impact Journals LLC 2016-03-07 /pmc/articles/PMC5078107/ /pubmed/26967051 http://dx.doi.org/10.18632/oncotarget.7960 Text en Copyright: © 2016 Yan et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Yan, Guifang
Li, Liqi
Zhu, Bo
Li, Yongsheng
Lipidome in colorectal cancer
title Lipidome in colorectal cancer
title_full Lipidome in colorectal cancer
title_fullStr Lipidome in colorectal cancer
title_full_unstemmed Lipidome in colorectal cancer
title_short Lipidome in colorectal cancer
title_sort lipidome in colorectal cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078107/
https://www.ncbi.nlm.nih.gov/pubmed/26967051
http://dx.doi.org/10.18632/oncotarget.7960
work_keys_str_mv AT yanguifang lipidomeincolorectalcancer
AT liliqi lipidomeincolorectalcancer
AT zhubo lipidomeincolorectalcancer
AT liyongsheng lipidomeincolorectalcancer